NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Temple Therapeutics

Temple Therapeutics

Private
Waltham, MassachusettsHealthcare & Life Scienceshttp://templetherapeutics.com/

Last Round

Early Funding

Dec 26, 2023

Total Funding Raised

$4.35M

Company Overview

Temple Therapeutics is a biotechnology company that develops novel therapies and diagnostics for women's health conditions such as endometriosis, ovarian cancer, and tissue fibrosis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Keywords

women's health therapeuticsFemTechovarian cancer treatmentendometriosis treatmentclinical stage biotechcompanion diagnosticsCDxpost-operative adhesionstargeted therapyprecision oncologynon-invasive diagnosticsAI drug discoveryAI digital pathologyLMTK3 targetnon-hormonal therapybiomarker discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Temple Therapeutics Comparables

Compare Temple Therapeutics with similar companies based on industry and business-model similarity.

Temple Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Temple Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingDec 26, 2023
VC RoundMay 3, 2022
GrantAug 27, 2019
Series BMar 13, 2018
View all Funding Rounds

Temple Therapeutics Investors

Notable investors and investment history

Temple Therapeutics investors
InvestorRounds
Eurostars SME programmeGrant
Dominick & Dickerman LLCSeries B
TerraNova Capital PartnersDebt
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2022

    $350K raised in a VC Round.

  • Aug 27, 2019

    $3M grant from Eurostars SME programme and other institutions.

View all signals

Temple Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Temple Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Temple Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersWaltham, Massachusetts
Year Founded2015
Last FundingDec 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.